Cetuximab Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 11, p. 1402
- Publication type:
- Article
Works matching DE "IMCLONE Systems Inc."
Results: 32
1
2
Announcements.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 8, p. 1017
- Publication type:
- Article
3
Data Available From Cetuximab Study in First-Line Treatment of Advanced Pancreatic Cancer.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 6, p. 707
- Publication type:
- Article
4
Cetuximab Survival Data Available From Study in First-Line Treatment of Advanced Head and Neck Cancer.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 5, p. 616
- Publication type:
- Article
5
FDA Approves Cetuximab to Treat Head and Neck Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 4, p. 412
- Publication type:
- Article
6
Briefs.
- Published in:
- Bio-IT World, 2009, v. 8, n. 1, p. 12
- Publication type:
- Article
7
Hubris and the Undoing of American Medicine.
- Published in:
- Hospital Topics, 2002, v. 80, n. 2, p. 35, doi. 10.1080/00185860209597994
- By:
- Publication type:
- Article
8
Promising drug is victim of bad business.
- Published in:
- Nature Medicine, 2002, v. 8, n. 3, p. 199, doi. 10.1038/nm0302-199a
- By:
- Publication type:
- Article
9
Lilly acquires ImClone for $6.5bn.
- Published in:
- Chemistry & Industry, 2008, n. 19, p. 5
- By:
- Publication type:
- Article
10
Business digest.
- Published in:
- Chemistry & Industry, 2008, n. 18, p. 13
- By:
- Publication type:
- Article
11
News in Brief.
- Published in:
- Chemistry & Industry, 2003, n. 2, p. 4
- Publication type:
- Article
12
Changing Ethical Attitudes: The Case of the Enron and ImClone Scandals.
- Published in:
- Social Science Quarterly (Wiley-Blackwell), 2006, v. 87, n. 2, p. 395, doi. 10.1111/j.1540-6237.2006.00387.x
- By:
- Publication type:
- Article
13
Cetuximab: Adverse Event Profile and Recommendations for Toxicity Management.
- Published in:
- Clinical Journal of Oncology Nursing, 2005, v. 9, n. 3, p. 322, doi. 10.1188/05.CJON.332-338
- By:
- Publication type:
- Article
14
MARTHA STEWART AND THE FORBIDDEN FRUIT: A NEW STORY OF EVE.
- Published in:
- Michigan State Law Review, 2009, v. 2009, n. 4, p. 1017
- By:
- Publication type:
- Article
15
News feature: 2008 in reflection.
- Published in:
- 2009
- By:
- Publication type:
- journal article
16
ImClone loses Erbitux patent.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 11, p. 886, doi. 10.1038/nrd2191
- By:
- Publication type:
- Article
17
Cetuximab.
- Published in:
- 2004
- By:
- Publication type:
- journal article
18
NEWS IN BRIEF.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 3, p. 194
- Publication type:
- Article
19
Biotech firm faces challenges from FDA, falling stock prices.
- Published in:
- 2002
- By:
- Publication type:
- journal article
20
FDA holds court on post hoc data linking KRAS status to drug response.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 2, p. 110, doi. 10.1038/nbt0209-110c
- By:
- Publication type:
- Article
21
Giants wrestle over ImClone.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 12, p. 1323, doi. 10.1038/nbt1208-1323b
- By:
- Publication type:
- Article
22
What's fueling the biotech engine—2007.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 11, p. 1227, doi. 10.1038/nbt1108-1227
- By:
- Publication type:
- Article
23
Big pharma swallows biotech's pride.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 9, p. 955, doi. 10.1038/nbt0908-955
- By:
- Publication type:
- Article
24
People.
- Published in:
- Nature Biotechnology, 2007, v. 25, n. 8, p. 948, doi. 10.1038/nbt0807-948
- Publication type:
- Article
25
News in Brief.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 7, p. 725, doi. 10.1038/nbt0703-725
- Publication type:
- Article
26
BUSINESS AND REGULATORY NEWS.
- Published in:
- Nature Biotechnology, 2002, v. 20, n. 12, p. 1181
- Publication type:
- Article
27
Former ImClone chief faces allegations of past misdeeds.
- Published in:
- Nature, 2002, v. 419, n. 6906, p. 421, doi. 10.1038/419421b
- By:
- Publication type:
- Article
28
Eli Lilly wins race to take control of ImClone.
- Published in:
- Nature, 2008, v. 455, n. 7214, p. 719, doi. 10.1038/455719d
- Publication type:
- Article
29
In brief.
- Published in:
- Nature, 2006, v. 444, n. 7115, p. 17, doi. 10.1038/444017a
- Publication type:
- Article
30
In brief.
- Published in:
- Nature, 2006, v. 439, n. 7076, p. 533, doi. 10.1038/439533b
- Publication type:
- Article
31
PHARMACY CORNER.
- Published in:
- Oncology Nursing Forum, 2004, v. 31, n. 3, p. 651, doi. 10.1188/04.ONF.651-652
- By:
- Publication type:
- Article
32
CORPORATE FALLOUT.
- Published in:
- Forensic Examiner, 2003, v. 12, n. 1/2, p. 22
- By:
- Publication type:
- Article